Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.52)
# 3,503
Out of 5,090 analysts
177
Total ratings
48%
Success rate
-0.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $8.05 | -0.62% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $195 → $205 | $178.37 | +14.93% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $101.36 | +15.43% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $94.28 | +0.76% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $575.34 | +12.98% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $11.69 | +2.65% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $136.51 | -30.41% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $80.73 | +5.29% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $44.59 | -66.36% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $304.49 | +12.65% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $2.01 | +596.52% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $18.54 | +158.90% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $86.19 | +18.34% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $97.52 | -40.53% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $16.82 | +18.91% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $65.49 | +100.03% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $125.08 | +6.33% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $364.02 | -39.56% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $120.50 | +213.69% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $8.05
Upside: -0.62%
iRhythm Technologies
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $178.37
Upside: +14.93%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $101.36
Upside: +15.43%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $94.28
Upside: +0.76%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $575.34
Upside: +12.98%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $11.69
Upside: +2.65%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $136.51
Upside: -30.41%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $80.73
Upside: +5.29%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $44.59
Upside: -66.36%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $304.49
Upside: +12.65%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $2.01
Upside: +596.52%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $18.54
Upside: +158.90%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $86.19
Upside: +18.34%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $97.52
Upside: -40.53%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $16.82
Upside: +18.91%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $65.49
Upside: +100.03%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $125.08
Upside: +6.33%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $364.02
Upside: -39.56%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $120.50
Upside: +213.69%